From Wikipedia, the free encyclopedia
|Systematic (IUPAC) name|
|Mol. mass||265.219 g/mol|
Nitecapone (INN; OR-462) is a drug which acts as a selective inhibitor of the enzyme catechol O-methyl transferase (COMT). It was patented as an antiparkinsonian agent but was never marketed.
- F.. Macdonald (1997). Dictionary of Pharmacological Agents. CRC Press. p. 1635. ISBN 978-0-412-46630-4. Retrieved 20 May 2012.
- Nissinen E, Lindén IB, Schultz E, Kaakkola S, Männistö PT, Pohto P (August 1988). "Inhibition of catechol-O-methyltransferase activity by two novel disubstituted catechols in the rat". European Journal of Pharmacology 153 (2-3): 263–9. PMID 3181288.
|This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it.|